Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT00951418
Eligibility Criteria:
Inclusion Criteria:
* Treated with clozapine for minimum 6 months.
* Fixed dosage of clozapine last month before inclusion.
Exclusion Criteria:
* Substance misuse.
* Depression (Calgary Depression score ≥7).
* Somatic disease that interfere with cognitive performance.
* Treatment with benzodiazepines (half-lives \>15 hours not allowed up 14 days prior inclusion and during study. Half-lives \< 15 hours not allowed 3 days prior cognitive testing).
* Electroconvulsive therapy.
* Treatment with other antipsychotics.
* Withdrawal of informed consent.
* Compulsory measures.
* Treatment with anticholinergics except for atropine drops administered sublingually.
* Changes in use of tobacco last month before inclusion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00951418
Study Brief:
Protocol Section:
NCT00951418